Two-day regimen of aciclovir for treatment of recurrent genital herpes simplex type 2 infection
doi: 10.1086/339325
Wald A, Carrell D, Remington M, Kexel E, Zeh J, Corey L. Two-day regimen of aciclovir for treatment of recurrent genital herpes simplex type 2 infection. Clin Infect Dis 2002; 34: 944-8. doi: 10.1086/339325
Valacyclovir for episodic treatment of genital herpes: A shorter 3-day treatment course compared with 5-day treatment
doi: 10.1086/339326
Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002; 34: 958-62. doi: 10.1086/339326
Psychosocial implications of recurrent genital herpes simplex virus infection
Goldmeier D, Johnson A, Byrne M, Barton S. Psychosocial implications of recurrent genital herpes simplex virus infection. Genitourin Med 1988; 64: 327-30.
Recurrent genital herpes treatments and their impact on quality of life
doi: 10.2165/00019053-200321120-00002
Brentjens MH, Yeung-Yue KA, Lee PC, Tyring SK. Recurrent genital herpes treatments and their impact on quality of life. Pharmacoeconomics 2003; 21: 853-63. doi: 10.2165/00019053-200321120-00002
Meads DM, McKenna SP, Bonney M, Bloch MT. Further validation and responsiveness assessment of the Herpes Outbreak Impact Questionnaire (HOIQ) and Herpes Symptom Checklist (HSC). Value in Health 2008, in press.
8
79960387188
Valaciclovir versus aciclovir in patient-initiated treatment of recurrent genital herpes: A randomised double-blind clinical trial
Bodsworth NJ, Crooks RJ, Borelli S, Vijlsgaard G, Paavonen J, Worm M, et al. Valaciclovir versus aciclovir in patient-initiated treatment of recurrent genital herpes: a randomised double-blind clinical trial. Genitourin Med 1997; 73: 110-6.
A double-blind, randomized study assessing the equivalence of valaciclovir 100mg once daily versus 500mg twice daily in the episodic treatment of recurrent genital herpes
doi: 10.1093/jac/44.4.525
Saiag P, Praindhui D, Chastang C. A double-blind, randomized study assessing the equivalence of valaciclovir 100mg once daily versus 500mg twice daily in the episodic treatment of recurrent genital herpes. J Antimicrob Chemother 1999; 44: 525-31. doi: 10.1093/jac/44.4.525
Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection
Patel R, Tyring S, Strand A, Price MJ, Grant DM. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect 1999; 75: 398-402.
The effect of suppressive oral aciclovir on the psychological morbidity associated with recurrent genital herpes
Carney O, Ross E, Ikkos G, Mindel A. The effect of suppressive oral aciclovir on the psychological morbidity associated with recurrent genital herpes. Genitourin Med 1993; 69: 457-9.